Literature DB >> 2020557

Dinucleotide repeat polymorphism at the human cysteine-proteinase inhibitor pseudogene (CSTP1).

M H Polymeropoulos1, H Xiao, D S Rath, C R Merril.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020557      PMCID: PMC333817          DOI: 10.1093/nar/19.5.1164

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  4 in total

1.  Dinucleotide repeat polymorphism at the D12S43 locus.

Authors:  J L Weber; A E Kwitek; P E May; M Polymeropoulos
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

2.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

3.  Human cysteine-proteinase inhibitors: nucleotide sequence analysis of three members of the cystatin gene family.

Authors:  E Saitoh; H S Kim; O Smithies; N Maeda
Journal:  Gene       Date:  1987       Impact factor: 3.688

4.  The human cystatin C gene (CST3) is a member of the cystatin gene family which is localized on chromosome 20.

Authors:  E Saitoh; L M Sabatini; R L Eddy; T B Shows; E A Azen; S Isemura; K Sanada
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

  4 in total
  2 in total

1.  Short tandem repeat polymorphisms in Japanese macaques: their short repeat lengths and low informativeness.

Authors:  Y Watanabe; T Sakazume; K Kurosaki; H Oota; K Washio-Watanabe; S Ueda
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

2.  Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction.

Authors:  G Deng; M Yu; L C Chen; D Moore; W Kurisu; A Kallioniemi; F M Waldman; C Collins; H S Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.